Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 26, 2014 FBO #4536
SOLICITATION NOTICE

68 -- Custom Synthesis of Peptides

Notice Date
4/24/2014
 
Notice Type
Presolicitation
 
NAICS
325199 — All Other Basic Organic Chemical Manufacturing
 
Contracting Office
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
 
ZIP Code
21702-5014
 
Solicitation Number
W81XWH14T0180
 
Response Due
5/9/2014
 
Archive Date
6/23/2014
 
Point of Contact
Jennifer Hayden, 301-619-1363
 
E-Mail Address
US Army Medical Research Acquisition Activity
(jennifer.e.hayden.civ@mail.mil)
 
Small Business Set-Aside
Total Small Business
 
Description
The United States Army Medical Research Acquisition Activity (USAMRAA) has a requirement for the United States Army Medical Research Institute of Chemical Defense (USAMRICD) for custom synthesis of peptides. This is a Request for Quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2001-27. This requirement is restricted to Small Businesses. The North American Industry Classification System (NAICS) code is 325199 with a size standard of 1,000 people. This code shall be listed in System for Award Management (SAM.gov) prior to award. The following are the Minimum Essential Characteristics for the requirement: Required for the custom synthesis of peptide molecules for botulinum neurotoxin inhibitor experiments using a FRET based reporter assay Peptide 1: DAB4(C)-RWTKCL-NH2 (S-S bond), 25mg Peptide 2: SNAP25[ac187-203ca]: Ac-SNKTRIDEANQRATKML-NH2, 25mg Peptide 3: DAB(C)-RWTKC-amide [S-S], 10mg Peptide 4: DAB(C)-WWTKCL-amide [S-S], 10mg Peptide 5: DAB(C)-RRTKCL-amide [S-S], 10mg Peptide 6: DAB(C)-RWPKCL-amide [S-S], 10mg Peptide 7: DAB(C)-RWVKCL-amide [S-S], 10mg Peptide 8: DAB(C)-RWIKCL-amide [S-S], 10mg Peptide 9: DAB(C)-RWAKCL-amide [S-S], 10mg Peptide 10: DAB(C)-RWSKCL-amide [S-S], 10mg Peptide 11: DAB(a)-RWTK-(a)-L [linear], 10 mg Peptide 12: DAB(A)-RWTAL-amide [linear], 10mg Peptide 13: DAB(a)-RWTaL-amide [stapled], 25mg Peptide 14: DAB(a)-RWTaL-amide [linear], 25mg Peptide 15: DAB(homoC)-RWTK(homoC)L-amide[S-S], 25 mg Peptide 16: DAB(homoC)-RWTKCL-amide[S-S], 25mg Peptide 17: DAB(C)-RWTK(homoC)L-amide[S-S], 25mg Must have the DAB (2, 4-diaminobutanoic acid) construct in the peptide sequence (except for Ac-SNKTRIDEANQRATKML-NH2). DAB(C) is a cysteine attached to side chain of DAB. DAB(A) is an alanine attached to side chain of DAB homoC is a homocysteine [S-S] is an intramolecular disulfide bond Peptide 11 contains (a) = S-(2)-propenyl alanine. Must use Fmoc-(s)-2-(2-prpenyl)-Ala-OH as starting material for synthesis of peptide 11. Peptide 13 is a stapled peptide: DAB(a) = staple (e.g., 2-(4'-pentenyl)alanine), attached to side chain of DAB; (a) = same staple between T and L. Cyclization should be achieved by olefin metathesis. Peptide 14 contains the same staple as peptide 12, but without cyclization. Peptide 1 has a DAB4 = 2, 4-diaminobutanoic acid. The cysteine is attached to the side chain of DAB4 and the remaining linear sequence is cyclized via the two cysteine residues. All peptides must have N-terminal amine and C-terminal amide. Must have purity by HPLC of no less than 90%. Must have a lead time of 4-5 weeks from receipt to delivery. All responsible sources may submit a quote, which shall be considered by the agency. The competitive solicitation, solicitation amendments and all questions and answers relating to this procurement shall be made available via the Internet at https://acquisition.army.mil/asfi/ or https://www.fedbizopps.gov. The solicitation is anticipated for release to the vendor community on or about April 24, 2014, and will only be available until May 9, 2014. Specifications of the requirement are provided in solicitation: W81XWH-14-T-0180. Potential offerors are responsible for accessing the website. Interested parties must respond to the solicitation in order to be considered for award of any resultant contract. To be eligible for an award, offerors SHALL be registered in the System for Award Management (SAM.gov) and have completed its representations and certification completed via SAM.gov. Contractors may obtain information on registration and annual confirmation requirements via www.SAM.gov. All questions should be addressed in writing to Jennifer Hayden, Contract Specialist at jennifer.e.hayden.civ@mail.mil. All interested parties shall provide their quote to Jennifer Hayden at jennifer.e.hayden.civ@mail.mil by 11:00 a.m. ET on May 9, 2014 in order to be considered for this solicitation.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH14T0180/listing.html)
 
Place of Performance
Address: US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD
Zip Code: 21702-5014
 
Record
SN03348219-W 20140426/140424235354-1138fa8a8e72bfff5c3cbaf7f9a136cd (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.